DGAP-News: Burcon NutraScience Corp.: CLARISOY(TM) FIRST COMMERCIAL SALES
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: CLARISOY(TM) FIRST COMMERCIAL SALES
20.12.2012 / 14:00
---------------------------------------------------------------------
CLARISOY(TM) FIRST COMMERCIAL SALES
Vancouver, British Columbia, December 19, 2012 - Burcon NutraScience
Corporation (TSX-BU; NASDAQ - BUR) ('Burcon' or the 'Corporation') is
pleased to announce that it has been notified by Archer Daniels Midland
Company ('ADM') of the first commercial sale of CLARISOY(TM) soy protein
produced by ADM.
Burcon's CLARISOY(TM), which is under license to ADM, is the world's only
vegetable-based protein capable of offering both clarity and complete
nutrition in low pH beverage systems. Extremely heat stable, CLARISOY(TM)
100 requires no homogenization or stabilizers in low pH beverages.
'Today's announcement of the first commercial sale of CLARISOY soy protein
is an historic milestone for Burcon and we are thrilled by the speed with
which ADM has brought this exciting protein to market.' said Johann F.
Tergesen, President and Chief Operating Officer, adding, 'Since licensing
Burcon's CLARISOY technology in March 2011, ADM has launched CLARISOY 100
at the 2011 IFT Expo; brought a first commercial production facility online
in early 2012; launched CLARISOY 150, the first extension to the CLARISOY
product line at the 2012 IFT Expo and has now made its first commercial
sale. We look forward to more commercial advancements for CLARISOY(TM) soy
protein.'
The CLARISOY(TM) Advantage
CLARISOY(TM) soy proteins are the world's only line of transparent soy
proteins. ADM's CLARISOY(TM) line includes a range of products for both
low and neutral pH applications allowing food and beverage companies to
easily include up to 10 grams of CLARISOY(TM) per serving.
CLARISOY(TM) 100 is a premier vegetable-based protein that offers both
clarity and complete protein nutrition for beverages with a pH of less than
4.
CLARISOY (TM) 150 is a revolutionary soy protein for neutral pH beverages
and low pH beverages with cloud systems. The clean flavor and smooth
mouth-feel makes CLARISOY(TM) a formulator's ideal protein ingredient.
In March 2011 Burcon entered into a License and Production Agreement with
ADM (the 'License Agreement') for the worldwide production, distribution
and sale of Burcon's CLARISOY(TM) soy protein. The License Agreement gives
ADM exclusive rights across all geographic regions and all potential
product applications to produce, market and sell CLARISOY soy protein. ADM
will make royalty payments to Burcon on the sales of CLARISOY under the
license agreement.
Burcon expects to release its third quarter financial results for the
three-month period ending December 31, 2012, on or about February 14, 2013
following the close of markets. Management will host a conference call
coinciding with the release of those results and will review the financial
results and also provide additional comments and discussion on CLARISOY
sales at that time.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We have developed
CLARISOY(TM) soy protein, which offers clarity and complete protein
nutrition for low pH beverage systems; Peazazz(TM) a uniquely soluble and
clean-tasting pea protein and Puratein(R), Supertein(TM) and Nutratein(TM)
canola protein isolates with unique functional and nutritional attributes.
Our team of highly specialized scientists and engineers work from our
private research facility to develop and optimize environmentally sound
technologies. To date, our patent portfolio consists of 215 issued patents
in various countries, including 35 issued U.S. patents, and in excess of
395 additional pending patent applications, 78 of which are U.S. patent
applications.
CLARISOY(TM) is under license from Archer Daniels Midland Company.
CLARISOY(TM) is a trademark of Archer Daniels Midland Company.
###
ON BEHALF OF THE BOARD OF DIRECTORS
'Johann F. Tergesen'
Johann F. Tergesen
President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking statements. All statements
other than statements of historical fact included in this release are
forward-looking statements, including, without limitation, statements
regarding the timing and use of proceeds of the Offering and the completion
of the Offering. There can be no assurance that such statements will prove
to be accurate and actual results and future events could differ materially
from those anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon's plans
and expectations include the actual results of marketing activities,
adverse general economic, market or business conditions, regulatory changes
and other risks and factors detailed herein and from time to time in the
filings made by Burcon with securities regulators and stock exchanges,
including in the section entitled 'Risk Factors' in Burcon's annual
information form dated June 25, 2012. Any forward-looking statement or
information only speaks as of the date on which it was made and, except as
may be required by applicable securities laws, Burcon disclaims any intent
or obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance and accordingly undue reliance should not be put on such.
For more information, please contact:
Michael Kirwan, Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
mkirwan(at)burcon.ca www.burcon.ca
End of Corporate News
---------------------------------------------------------------------
20.12.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
197604 20.12.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="EUROPEAN URANIUM SIGNS MEMORANDUM OF UNDERSTANDING WITH SLOVAK MINISTRY OF ECONOMY
Datum: 20.12.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 214764
Anzahl Zeichen: 4143
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 321 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: CLARISOY(TM) FIRST COMMERCIAL SALES"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
